It’s hard to drive anywhere in the Pittsburgh area without spotting a traffic cone or two — a sign of ongoing construction.
Discover why Elizabethtown, PA is one of 2024’s most popular small towns, with new Ryan Homes communities, great amenities, ...
Developers are planning a 23-home New Albany subdivision featuring accessible, single-level luxury homes starting around $400 ...
Pittsburgh homeowners are paying more for electricity than at any point in the past decade. Duquesne Light’s residential rates have climbed steadily since 2020, and the trajectory isn’t slowing down.
Discussions about Pittsburgh’s housing stock last year led to public bickering by the city’s mayoral candidates. During a debate before the May primary, Pittsburgh Mayor Corey O’Connor slammed his ...
Mike Darnay is a digital producer and photojournalist at CBS Pittsburgh. Mike has also written and produced content for Vox Media and the Mon Valley Independent. He often covers overnight breaking ...
Construction is ramping up on an expansive new mixed-use development near North Hills. Apartments, a private greenway, pedestrian bridges and more retail space are among the expansions announced ...
Roofers are turning down jobs. Painters are locking themselves inside the homes they’re finishing. Concrete crews have monthslong waiting lists. In the Twin Cities and surrounding suburbs, the Trump ...
One well-worn refrain of progressive urban politics is that new, “luxury” housing will not help solve the housing shortage. A 2024 study of U.S. voters found that 30 to 40 percent believed more ...
PENNSYLVANIA, USA — New federal requirements are now in effect for Supplemental Nutrition Assistance Program (SNAP) recipients in Pennsylvania, changing what documentation households must provide to ...
Add Yahoo as a preferred source to see more of our stories on Google. A home in Pittsburgh’s South Side Slopes neighborhood has caused neighbors who live on Salisbury Street great concern, after they ...
With $55 billion earmarked to bolster its U.S. operations, Johnson & Johnson is the latest drugmaker to zero in on expansion plans that are aimed, at least in part, at abating the Trump administration ...